Affimed
AFMD
$5.03
Share price
3.07%
Change (1 day)
440.86%
Change (1 year)
Categories
Operating Margin for Affimed (AFMD)
Operating Margin as of April 2024 (TTM): -210.66%
According to Affimed 's latest financial reports and stock price the company's current Operating Margin is -210.66%. At the end of 2021 the company had an Operating Margin of -142.50%.
Operating Margin history for Affimed from 2013 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -142.50% | -2.3% |
| 2020 | -145.86% | -3.59% |
| 2019 | -151.28% | 84.37% |
| 2018 | -82.06% | -94.55% |
| 2017 | -1,504.63% | 194.36% |
| 2016 | -511.15% | 90.98% |
| 2015 | -267.64% | 2029.79% |
| 2014 | -12.57% | -97.55% |
| 2013 | -513.07% | -57.98% |
| 2012 | -1,221.06% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | 27.34% | -112.98% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | -106.40% | -49.49% | 🇺🇸 USA |
 Agenus
AGEN | -9.71% | -95.39% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -84.50% | -59.89% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.